Abbvie Inc
ABBV
$185.3-0.19 (-0.10%)
Jun 22, 2025, 4:00 PM
Financials
| 52Week High | 218.66 | 52Week Low | 163.52 |
| Beta | 0.51 | Current Ratio Annual | 0.66 |
| Current Ratio Quarterly | 0.76 | Gross Margin TTM | 70.69 |
| Market Cap | 327.31B | Net Profit Margin TTM | 7.31 |
| Operating Margin TTM | 17.56 | Price To Book | 230.50 |
| Price To Earnings TTM | 78.02 | Price To Free Cash Flow TTM | 21.27 |
| Price To Sales TTM | 5.71 | Quick Ratio Annual | 0.43 |
| Quick Ratio Quarterly | 0.48 | Return On Assets TTM | 3.01 |
| Return On Equity TTM | 95.59 | Return On Investment TTM | 5.66 |
| Revenue Growth3Y | 0.08 | Revenue Growth5Y | 11.11 |
| Revenue Growth Quarterly Yoy | 8.39 | Revenue Growth TTMYoy | 5.45 |
| Revenue Per Share TTM | 32.37 |
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 3632 | 2 | 3 | 31 | 30 | 14 | 1.30B | $223.77B |
| Mar 31, 2025 | 3495 | 217 | 294 | 1385 | 1463 | 383 | 1.28B | $258.21B |
| Change | 137(4%) | 215(10750%) | 291(9700%) | 1.35K(4368%) | 1.43K(4777%) | 369(2636%) | 21.86M(2%) | $34.44B(15%) |